Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Cerevel Therapeutics Holdings, Inc. CERE

Set alert

Price alert · CERE

All alert types
44.96 +44.96 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
8.19B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-15.40
Beta
1.41
Short ratio
2.37
Inst. own
85.12%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
41.63
200-d avg
39.55
1y target
43.40

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CERE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

6.31 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -15.9×
FY 2012: -5.7×FY 2013: -5.2×FY 2014: -5.8×FY 2015: -2.6×FY 2018: -1.8×FY 2019: -11.8×FY 2020: -12.9×FY 2021: -19.9×FY 2022: -13.6×FY 2023: -15.9×
FY 2012 5y median -13.6× FY 2023
P/S 0.0×
FY 2012: 31.5×FY 2013: 32.3×FY 2014: 70.5×FY 2015: 27.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2012 5y median 0.0× FY 2023
P/B 10.2×
FY 2012: 2.7×FY 2013: 5.1×FY 2014: 6.1×FY 2015: 17.4×FY 2018: 0.0×FY 2019: 19.4×FY 2020: 5.1×FY 2021: 7.7×FY 2022: 9.2×FY 2023: 10.2×
FY 2012 5y median 9.2× FY 2023
P/FCF -19.9×
FY 2012: -6.4×FY 2013: -5.9×FY 2014: -7.2×FY 2015: -3.1×FY 2018: 0.0×FY 2019: -21.1×FY 2020: -14.3×FY 2021: -23.4×FY 2022: -16.1×FY 2023: -19.9×
FY 2012 5y median -19.9× FY 2023
EV/EBITDA -15.3×
FY 2012: -5.6×FY 2013: -5.3×FY 2014: -6.0×FY 2015: -2.5×FY 2018: 0.0×FY 2019: -39.7×FY 2020: -10.8×FY 2021: -20.1×FY 2022: -14.8×FY 2023: -15.3×
FY 2012 5y median -15.3× FY 2023
EV/Sales 0.0×
FY 2012: 27.7×FY 2013: 30.7×FY 2014: 69.1×FY 2015: 25.6×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2012 5y median 0.0× FY 2023
FCF Yield -5.0%
FY 2012: -15.7%FY 2013: -17.0%FY 2014: -13.9%FY 2015: -32.2%FY 2018: 0.0%FY 2019: -4.7%FY 2020: -7.0%FY 2021: -4.3%FY 2022: -6.2%FY 2023: -5.0%
FY 2012 5y median -5.0% FY 2023

Profitability

Gross Margin 0.0%
FY 2012: 55.6%FY 2013: -19.1%FY 2014: -25.7%FY 2015: -93.6%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2012 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2012: -536.3%FY 2013: -621.6%FY 2014: -1217.0%FY 2015: -1035.9%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2012 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2012: -547.6%FY 2013: -620.1%FY 2014: -1219.7%FY 2015: -1035.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2012 5y median 0.0% FY 2023
ROE -64.2%
FY 2012: -47.0%FY 2013: -98.5%FY 2014: -106.2%FY 2015: -668.3%FY 2018: 0.0%FY 2019: -165.0%FY 2020: -39.6%FY 2021: -38.4%FY 2022: -67.4%FY 2023: -64.2%
FY 2012 5y median -64.2% FY 2023
ROIC -38.7%
FY 2012: -45.7%FY 2013: -4374.5%FY 2014: 1798.2%FY 2015: 728.8%FY 2018: 0.0%FY 2019: -76.9%FY 2020: -35.7%FY 2021: -33.5%FY 2022: -38.8%FY 2023: -38.7%
FY 2012 5y median -38.7% FY 2023
ROA -34.8%
FY 2012: -42.5%FY 2013: -685.6%FY 2014: -947.4%FY 2015: -2076.4%FY 2018: 0.0%FY 2019: -106.3%FY 2020: -34.2%FY 2021: -32.3%FY 2022: -34.5%FY 2023: -34.8%
FY 2012 5y median -34.5% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2012: 0.0%FY 2013: -2.4%FY 2014: -54.1%FY 2015: 13.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2012 FY 2023
Operating Income -21.6%
FY 2012: 0.0%FY 2013: -13.2%FY 2014: 10.2%FY 2015: 3.7%FY 2018: 0.0%FY 2019: 82.7%FY 2020: -78.7%FY 2021: -47.6%FY 2022: -67.1%FY 2023: -21.6%
FY 2012 FY 2023
EPS (diluted) -15.1%
FY 2012: 0.0%FY 2013: -327400.0%FY 2014: 38.2%FY 2015: -464.2%FY 2018: 0.0%FY 2019: 84.6%FY 2020: -27.7%FY 2021: -26.4%FY 2022: -42.3%FY 2023: -15.1%
FY 2012 FY 2023
Free Cash Flow -16.5%
FY 2012: 0.0%FY 2013: -8.2%FY 2014: 18.0%FY 2015: -0.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -90.3%FY 2021: -38.3%FY 2022: -57.2%FY 2023: -16.5%
FY 2012 FY 2023

Financial Health

Current Ratio 10.9×
FY 2012: 9.1×FY 2013: 8.1×FY 2014: 6.2×FY 2015: 1.9×FY 2018: 0.0×FY 2019: 5.9×FY 2020: 13.2×FY 2021: 13.6×FY 2022: 12.5×FY 2023: 10.9×
FY 2012 5y median 12.5× FY 2023
Quick Ratio 10.9×
FY 2012: 8.9×FY 2013: 8.1×FY 2014: 6.2×FY 2015: 1.9×FY 2018: 0.0×FY 2019: 5.9×FY 2020: 13.2×FY 2021: 13.6×FY 2022: 12.5×FY 2023: 10.9×
FY 2012 5y median 12.5× FY 2023
Debt / Equity 0.7×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 1.0×FY 2018: 0.0×FY 2019: 0.4×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.7×FY 2023: 0.7×
FY 2012 5y median 0.4× FY 2023
Net Debt / EBITDA 1.2×
FY 2012: 0.8×FY 2013: 0.3×FY 2014: 0.1×FY 2015: 0.1×FY 2018: 0.0×FY 2019: 1.4×FY 2020: 2.4×FY 2021: 0.7×FY 2022: -0.7×FY 2023: 1.2×
FY 2012 5y median 1.2× FY 2023
Interest Coverage -42.3×
FY 2012: -51.4×FY 2013: 0.0×FY 2014: -430×FY 2015: -939×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -38.2×FY 2023: -42.3×
FY 2012 5y median 0.0× FY 2023

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2012 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2012 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31